One pill a day? HIV study tests simpler combo

NCT ID NCT00196599

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a once-daily combination of three HIV drugs (FTC, ddI, efavirenz) in 39 adults who had never taken HIV medication before. The goal was to see if this simpler, once-a-day pill routine worked well and had fewer side effects than older treatments. Participants had HIV and a CD4 count above 100, but were otherwise healthy. The study measured how well the drugs controlled the virus and tracked safety and adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIRETROVIRAL NAIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Maladies Infectieuses, Hôpital Saint-Louis

    Paris, 75475, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.